BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11977548)

  • 1. [A patient with metastatic gastrointestinal stromal tumor who responded to STI571].
    Terashima M; Abe K; Takeda Y; Saito K; Uesugi N; Kato K; Sato K; Maekawa T
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):607-10. PubMed ID: 11977548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
    Miyake M; Takeda Y; Hasuike Y; Kashiwazaki M; Mishima H; Ikenaga M; Mano M; Takada Y; Hirota S; Tsujinaka T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1791-4. PubMed ID: 15553717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastatic gastrointestinal stromal tumors responded to the treatment with STI571 after polysurgery for recurrent lesions--report of two cases].
    Sasaki K; Doi T; Matsumoto G; Tsuruta K; Okamoto A; Funada N
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):1021-5. PubMed ID: 12894723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor.
    Sawaki A; Ohashi K; Yamao K; Inada K; Shimizu Y; Matsuura A; Nakamura T; Suzuki T; Hara K; Okubo K; Ohno R
    J Gastroenterol; 2003; 38(7):690-4. PubMed ID: 12898363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of postoperative recurrence of gastric GIST treated by imatinib].
    Kikuchi H; Konn H; Kamiya K; Baba M; Ohta M; Kondo K; Hiramatsu Y; Yamamoto M; Tanaka T; Sugimura H; Ohashi M; Kanda T; Nakamura S
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1569-73. PubMed ID: 15508453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with STI571, a tyrosine kinase inhibitor, for gastrointestinal stromal tumor with peritoneal dissemination and multiple liver metastases.
    Yamamoto S; Kubo S; Shuto T; Yamamoto T; Hirohashi K; Tanaka H; Takemura S; Kanazawa A; Kinoshita H
    J Gastroenterol; 2003; 38(9):896-9. PubMed ID: 14564636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
    Joensuu H; Roberts PJ; Sarlomo-Rikala M; Andersson LC; Tervahartiala P; Tuveson D; Silberman S; Capdeville R; Dimitrijevic S; Druker B; Demetri GD
    N Engl J Med; 2001 Apr; 344(14):1052-6. PubMed ID: 11287975
    [No Abstract]   [Full Text] [Related]  

  • 8. [New orientations in the management of advanced, metastatic gastrointestinal stromal tumors (GIST): combination of surgery and systemic therapy with imatinib in a case of primary gastric location].
    Catani M; De Milito R; Simi M
    Chir Ital; 2005; 57(1):127-33. PubMed ID: 15832750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients.
    Sawaki A; Yamao K; Nakamura T; Suzuki T; Okubo K; Hara K; Kawai H; Yamamura Y; Ito S; Mochiduki Y; Ohno R
    J Gastroenterol; 2004; 39(4):329-33. PubMed ID: 15168243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
    Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
    Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastrointestinal stromal tumors: a broad clinical spectrum from incidental -discovery to acute gastrointestinal bleeding].
    Siewert E; Tietze L; Maintz C; Geier A; Dietrich CG; Matern S; Gartung C
    Z Gastroenterol; 2004 Mar; 42(3):233-42. PubMed ID: 15022111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate].
    Aoyama T; Saeki H; Samejima J; Fujii K; Ishikawa Y; Kawamoto M; Fujisawa J; Matsukawa H; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):975-8. PubMed ID: 19542718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A patient with diffuse peritoneal metastases of GIST who was administered STI571].
    Mukaide H; Hasuike Y; Takeda Y; Shin E; Mishima H; Nishisyou I; Tujinaka T; Kawahara K; Kurata A
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2329-32. PubMed ID: 12484066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively].
    Okuda H; Tanaka H; Ueno M; Shitani M; Nasuno M; Suzuki C; Nishimura S; Kimura H; Yonezawa K; Abe T; Yoshida Y; Kawabata M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1941-4. PubMed ID: 16282731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two cases of gastrointestinal stromal tumor (GIST) of the stomach and a consideration of its malignancy potential and treatment strategy - report of two cases].
    Asakage N; Kobayashi S; Gotou T; Sasaki M; Tsukada K; Suzuki T; Yamamoto T; Sekine M; Miyazaki E; Hirai S; Yamasaki S
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):919-23. PubMed ID: 17565257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
    Shen L; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib].
    Sakakura C; Miyagawa K; Fukuda K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Yamaoka N; Sagara Y; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1739-41. PubMed ID: 16315926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate].
    Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate].
    Nakatani K; Tanabe S; Nishimura K; Shimoda T; Azuma M; Katada C; Sasaki T; Higuchi K; Koizumi W; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):997-1000. PubMed ID: 16835496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.